|Description||ML-098, also called as CID-7345532, is an activator of the GTP-binding protein Rab7 (EC50 = 77.6 nM) with selectivity without disrupting related GTPases cdc42, Ras, Rab-2A, and Rac1 (EC50s = 588.8, 346.7, 158.5, and 794.3 nM, respectively).|
|Brife Description||An activator of the GTP-binding protein Rab7 (EC50 = 77.6 nM)|
|Synonyms||1-[2-(2,5-dimethylphenoxy)ethyl]indole-3-carboxylic acid; ML 098; ML098; CID-7345532; CID 7345532; CID7345532|
|Solubility||DMSO: ≥ 29 mg/mL|
|Storage||Store in a cool and dry place (or refer to the Certificate of Analysis).|
|Boiling Point||535.5±45.0 ℃ at 760 Torr|
CCG-1423 is a novel inhibitor of RhoA/C-mediated gene transcription that is capable of inhibiting invasion of PC-3 prostate cancer cells in a Matrigel model of ...
Salirasib is a salicylic acid derivative with potential antineoplastic activity. Salirasib dislodges all Ras isoforms from their membrane-anchoring sites, there...
K-Ras G12C-IN-3 is a novel and irreversible inhibitor of mutant K-ras G12C.
ML-098, also called as CID-7345532, is an activator of the GTP-binding protein Rab7 (EC50 = 77.6 nM) with selectivity without disrupting related GTPases cdc42, ...
K-Ras(G12C) inhibitor 12
K-Ras(G12C) inhibitor 12 is an allosteric inhibitor of oncogenic K-Ras(G12C).
MDK30165, also known as K-Ras(G12C) Inhibitor 6, is an irreversible, allosteric inhibitor of the K-Ras(G12C) mutant that causes 100% modification of the protein...
ARS-853 is a selective, allele-specific inhibitor of KRAS, which blocks KRAS signaling and suppresses tumor growth (IC50= 2.5 μM).
K-Ras G12C-IN-2 is a novel and irreversible inhibitor of mutant K-ras G12C.
Pan-RAS-IN-1 is a pan-Ras inhibitor and exhibits lethality in cells partially dependent on expression of Ras proteins.
BQU57, a derivative of RBC8, is a selective GTPase Ral inhibitor relative to the GTPases Ras and RhoA.
6H05 is a selective inhibitor of oncogenic mutant K-Ras(G12C) without affecting wild-type K-Ras.
Oncrasin-1 is a potent and effective anticancer inhibitor that kills various human lung cancer cells with K-Ras mutations at low or submicromolar concentrations...
CASIN is a selective GTPase Cdc42 inhibitor ( IC50=2 uM), reduces active levels of Cdc42 in aged hematopoietic stem cells.
K-Ras G12C-IN-1 is a novel and irreversible inhibitor of mutant K-ras G12C.